Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook for long-term growth and profitability. The company uses AI to manage patient testing and help physicians generate timely diagnoses and treatment regimens. While slow to gain traction in 2024, 2025 is expected to be a pivotal year as the adoption of AI services broadens and deepens within critical sectors.
Healthcare is one of the critical sectors expected to benefit from AI efficiency at virtually all levels, including internal operations, CEM, patient satisfaction, and outcomes. It is forecasted to grow at a nearly 40% CAGR for the next five years.
